Global Pharmaceutical Company Bristol Myers Squibb Agrees to $75 Million Nationwide Settlement
Pharmaceutical company Bristol Myers Squibb has reached a $75 million settlement with state and federal agencies, resolving allegations that it underpaid the drug rebates owed to state Medicaid programs.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.